How many insider trades does FilingIQ track for GMED?

FilingIQ tracks 355 Form 4 insider transactions for GMED (GLOBUS MEDICAL INC), covering filings from Mar 12, 2014 onwards. 3 of those were filed in the last 90 days.

Are GMED insiders net buyers or net sellers?

Across the full Form 4 history for GMED, 3 transactions (1%) were open-market purchases and 142 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GMED insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GMED in?

GLOBUS MEDICAL INC (GMED) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $12.04B.

GMED insider trading

NYSE Healthcare

GLOBUS MEDICAL INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

355

Last 90 days

Buys / sells

1% / 40%

Market cap

$12.04B

About GLOBUS MEDICAL INC

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Company website: www.globusmedical.com

GMED insider activity at a glance

FilingIQ has scored 355 insider transactions for GMED since Mar 12, 2014. The most recent filing in our index is dated Feb 25, 2026.

Across the full history, 3 open-market purchases and 142 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GMED insider trades is 63.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GMED trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding GMED

Foresight Group Ltd Liability Partnership

$11.99M · 1.7% of AUM

Frequently asked

How many insider trades does FilingIQ track for GMED?: FilingIQ tracks 355 Form 4 insider transactions for GMED (GLOBUS MEDICAL INC), covering filings from Mar 12, 2014 onwards. 3 of those were filed in the last 90 days.
Are GMED insiders net buyers or net sellers?: Across the full Form 4 history for GMED, 3 transactions (1%) were open-market purchases and 142 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GMED insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GMED in?: GLOBUS MEDICAL INC (GMED) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $12.04B.

Methodology & sources

Every GMED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.